Botanix Pharmaceuticals Limited (BOT.AX)
AUD 0.36
(-4.05%)
AUD 0.36
(-4.05%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 | 112.46 Million AUD | 352.83% |
| 2023 | 24.83 Million AUD | 76.93% |
| 2022 | 14.03 Million AUD | -36.05% |
| 2021 | 21.95 Million AUD | -13.28% |
| 2020 | 25.31 Million AUD | 386.76% |
| 2019 | 5.19 Million AUD | -70.64% |
| 2018 | 17.71 Million AUD | 199.8% |
| 2017 | 5.9 Million AUD | 59.8% |
| 2016 | 3.69 Million AUD | 179.94% |
| 2015 | 1.32 Million AUD | -48.28% |
| 2014 | 2.55 Million AUD | 31198.96% |
| 2013 | 8158.00 AUD | -54.31% |
| 2012 | 17.85 Thousand AUD | -58.03% |
| 2011 | 42.54 Thousand AUD | -27.38% |
| 2010 | 58.59 Thousand AUD | -97.09% |
| 2009 | 2.01 Million AUD | -14.83% |
| 2008 | 2.36 Million AUD | -32.35% |
| 2007 | 3.5 Million AUD | 39.57% |
| 2006 | 2.5 Million AUD | -31.85% |
| 2005 | 3.67 Million AUD | 51.68% |
| 2004 | 2.42 Million AUD | -17.42% |
| 2003 | 2.93 Million AUD | -34.79% |
| 2002 | 4.5 Million AUD | -23.17% |
| 2001 | 5.86 Million AUD | 11.31% |
| 2000 | 5.26 Million AUD | -67.38% |
| 1999 | 16.14 Million AUD | -46.81% |
| 1998 | 30.36 Million AUD | -39.59% |
| 1997 | 50.26 Million AUD | -11.89% |
| 1996 | 57.04 Million AUD | -16.3% |
| 1995 | 68.15 Million AUD | 40.34% |
| 1994 | 48.56 Million AUD | 27.7% |
| 1993 | 38.03 Million AUD | 46.72% |
| 1992 | 25.92 Million AUD | -5.44% |
| 1991 | 27.41 Million AUD | 7.15% |
| 1990 | 25.58 Million AUD | 6.32% |
| 1989 | 24.06 Million AUD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 FY | 112.46 Million AUD | 352.83% |
| 2024 Q2 | 47.68 Million AUD | 0.0% |
| 2024 Q4 | 112.46 Million AUD | 0.0% |
| 2023 Q2 | 20.78 Million AUD | 0.0% |
| 2023 Q4 | 24.83 Million AUD | 0.0% |
| 2023 FY | 24.83 Million AUD | 76.93% |
| 2022 FY | 14.03 Million AUD | -36.05% |
| 2022 Q4 | 14.03 Million AUD | 0.0% |
| 2022 Q2 | 17.29 Million AUD | 0.0% |
| 2021 Q2 | 26.74 Million AUD | 0.0% |
| 2021 FY | 21.95 Million AUD | -13.28% |
| 2021 Q4 | 21.95 Million AUD | 0.0% |
| 2020 Q2 | 35.52 Million AUD | 0.0% |
| 2020 Q4 | 25.31 Million AUD | 0.0% |
| 2020 FY | 25.31 Million AUD | 386.76% |
| 2019 FY | 5.19 Million AUD | -70.64% |
| 2019 Q2 | 13.88 Million AUD | 0.0% |
| 2019 Q4 | 5.19 Million AUD | 0.0% |
| 2018 Q4 | 17.71 Million AUD | 0.0% |
| 2018 FY | 17.71 Million AUD | 199.8% |
| 2018 Q2 | 4.13 Million AUD | 0.0% |
| 2017 Q4 | 5.9 Million AUD | 0.0% |
| 2017 FY | 5.9 Million AUD | 59.8% |
| 2017 Q2 | 2.41 Million AUD | 0.0% |
| 2016 Q2 | 15.89 Thousand AUD | 0.0% |
| 2016 Q4 | 3.69 Million AUD | 0.0% |
| 2016 FY | 3.69 Million AUD | 179.94% |
| 2015 FY | 1.32 Million AUD | -48.28% |
| 2015 Q4 | 1.32 Million AUD | 0.0% |
| 2014 Q4 | 2.55 Million AUD | 0.0% |
| 2014 FY | 2.55 Million AUD | 31198.96% |
| 2013 Q4 | 8158.00 AUD | 0.0% |
| 2013 FY | 8158.00 AUD | -54.31% |
| 2012 FY | 17.85 Thousand AUD | -58.03% |
| 2012 Q4 | 17.85 Thousand AUD | 0.0% |
| 2011 FY | 42.54 Thousand AUD | -27.38% |
| 2011 Q4 | 42.54 Thousand AUD | 0.0% |
| 2010 Q4 | 58.59 Thousand AUD | 0.0% |
| 2010 FY | 58.59 Thousand AUD | -97.09% |
| 2009 FY | 2.01 Million AUD | -14.83% |
| 2009 Q4 | 2.01 Million AUD | 0.0% |
| 2008 FY | 2.36 Million AUD | -32.35% |
| 2008 Q4 | 2.36 Million AUD | 0.0% |
| 2007 FY | 3.5 Million AUD | 39.57% |
| 2007 Q4 | 3.5 Million AUD | 0.0% |
| 2006 Q4 | 2.5 Million AUD | 0.0% |
| 2006 FY | 2.5 Million AUD | -31.85% |
| 2005 FY | 3.67 Million AUD | 51.68% |
| 2005 Q4 | 3.67 Million AUD | 0.0% |
| 2004 FY | 2.42 Million AUD | -17.42% |
| 2004 Q4 | 2.42 Million AUD | 0.0% |
| 2003 Q4 | 2.93 Million AUD | 0.0% |
| 2003 FY | 2.93 Million AUD | -34.79% |
| 2002 FY | 4.5 Million AUD | -23.17% |
| 2002 Q4 | 4.5 Million AUD | 0.0% |
| 2001 FY | 5.86 Million AUD | 11.31% |
| 2001 Q4 | 5.86 Million AUD | 0.0% |
| 2000 FY | 5.26 Million AUD | -67.38% |
| 2000 Q4 | 5.26 Million AUD | 0.0% |
| 1999 FY | 16.14 Million AUD | -46.81% |
| 1999 Q4 | 16.14 Million AUD | 0.0% |
| 1998 FY | 30.36 Million AUD | -39.59% |
| 1997 Q4 | 50.26 Million AUD | 0.0% |
| 1997 FY | 50.26 Million AUD | -11.89% |
| 1996 FY | 57.04 Million AUD | -16.3% |
| 1995 FY | 68.15 Million AUD | 40.34% |
| 1994 FY | 48.56 Million AUD | 27.7% |
| 1993 FY | 38.03 Million AUD | 46.72% |
| 1992 FY | 25.92 Million AUD | -5.44% |
| 1991 FY | 27.41 Million AUD | 7.15% |
| 1990 FY | 25.58 Million AUD | 6.32% |
| 1989 FY | 24.06 Million AUD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| AdAlta Limited | 5.57 Million AUD | -1918.026% |
| Acrux Limited | 8.96 Million AUD | -1154.765% |
| Actinogen Medical Limited | 21.31 Million AUD | -427.709% |
| AnteoTech Limited | 9.38 Million AUD | -1098.832% |
| Argenica Therapeutics Limited | 16.37 Million AUD | -586.7% |
| Arovella Therapeutics Limited | 13.28 Million AUD | -746.574% |
| Anatara Lifesciences Ltd | 1.67 Million AUD | -6628.679% |
| Alterity Therapeutics Limited | 19.22 Million AUD | -485.03% |
| Amplia Therapeutics Limited | 14.84 Million AUD | -657.587% |
| Avecho Biotechnology Limited | 7.31 Million AUD | -1436.547% |
| Bio-Gene Technology Limited | 3.15 Million AUD | -3459.469% |
| Biome Australia Limited | 8.27 Million AUD | -1258.795% |
| Biotron Limited | 493.47 Thousand AUD | -22690.293% |
| BTC Health Limited | 5.14 Million AUD | -2084.285% |
| Chimeric Therapeutics Limited | 15.27 Million AUD | -636.355% |
| CSL Limited | 56.93 Billion AUD | 99.802% |
| Clarity Pharmaceuticals Ltd | 154.62 Million AUD | 27.268% |
| Clinuvel Pharmaceuticals Limited | 231.12 Million AUD | 51.34% |
| Cynata Therapeutics Limited | 8.38 Million AUD | -1240.734% |
| Dimerix Limited | 32.07 Million AUD | -250.591% |
| EZZ Life Science Holdings Limited | 25.55 Million AUD | -340.141% |
| Hexima Limited | 2.26 Million AUD | -4856.564% |
| Island Pharmaceuticals Limited | 2.56 Million AUD | -4285.49% |
| Immuron Limited | 15.54 Million AUD | -623.247% |
| Immutep Limited | 147.44 Million AUD | 23.726% |
| Imugene Limited | 151.39 Million AUD | 25.716% |
| Invex Therapeutics Ltd | 6.12 Million AUD | -1737.642% |
| Memphasys Limited | 12.43 Million AUD | -804.773% |
| Nanollose Limited | 241.95 Thousand AUD | -46382.398% |
| Neuren Pharmaceuticals Limited | 247.97 Million AUD | 54.646% |
| Noxopharm Limited | 6.78 Million AUD | -1557.851% |
| NeuroScientific Biopharmaceuticals Limited | 5.43 Million AUD | -1968.934% |
| Nyrada Inc. | 5.9 Million AUD | -1803.836% |
| Orthocell Limited | 26.61 Million AUD | -322.558% |
| PharmAust Limited | 11.12 Million AUD | -910.932% |
| Patrys Limited | 4.16 Million AUD | -2602.45% |
| Paradigm Biopharmaceuticals Limited | 27.39 Million AUD | -310.598% |
| Proteomics International Laboratories Limited | 10.87 Million AUD | -934.147% |
| Prescient Therapeutics Limited | 20.39 Million AUD | -451.49% |
| PYC Therapeutics Limited | 91.23 Million AUD | -23.264% |
| Race Oncology Limited | 20.22 Million AUD | -455.969% |
| Radiopharm Theranostics Limited | 72.03 Million AUD | -56.122% |
| Recce Pharmaceuticals Ltd | 6.36 Million AUD | -1665.643% |
| Starpharma Holdings Limited | 36.81 Million AUD | -205.494% |
| Telix Pharmaceuticals Limited | 398.3 Million AUD | 71.764% |
| Tissue Repair Ltd | 19.38 Million AUD | -480.026% |
| Zelira Therapeutics Limited | 5.18 Million AUD | -2069.701% |